aod9604 vs retatrutide AOD Peptide Blend: Lipolysis Research aod9604 vs retatrutide Retatrutide Explained:

Among patients without diabetes or prior pancreatitis, five-year data showed lower pancreatitis rates on GLP-1s (0.3% vs 0.4%)

But for select candidates, it can improve tightness and texture

And there are so many different formulations and combinations out there, and theyre not evaluated by the FDA, just to note that

[8] [9] Lean muscle mass loss : Significant weight reduction may include loss of lean tissue, which could have implications for long-term metabolic health and physical function, particularly in older adults

Both are highly effective GLP-1 medications, but Tirzepatide also acts on another receptor (GIP), which can lead to greater weight loss for some individuals